Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

JNJ 105.55 -1.26 (-1.18%)
price chart
Johnson & Johnson to Remove Formaldehyde From Products
Johnson & Johnson, which makes a range of personal care products like baby shampoo, acne cream and antiwrinkle lotion, announced plans Wednesday to remove a host of potentially harmful chemicals, like formaldehyde, from its line of consumer products ...
Johnson & Johnson Pledges To Purge Controversial Chemicals  NPR (blog)
Johnson & Johnson to Remove Formaldehyde, Other Chemicals from Products  TIME
Related articles »  
Johnson & Johnson Announces a Ban on Harmful Chemicals in Products
Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.
The Real Lesson of Formaldehyde In Baby Shampoo  TIME
Time for companies to pledge to remove dangerous chemicals from products  Fox News
Related articles »  
Berkshire Cuts Johnson & Johnson Stake
Berkshire pared its holdings of Johnson & Johnson (JNJ) by about two-thirds to 10.3 million shares. The world's biggest health- products maker was ordered in April to pay more than $1.1 billion in fines after an Arkansas jury found the firm misled ...
Berkshire Cuts Johnson & Johnson, Adds National Oilwell  Businessweek
Buffett's Berkshire cuts stakes in J&J, Kraft, P&G  MarketWatch
Related articles »  
Johnson & Johnson Eyes China's Baby Market
Johnson & Johnson is rumored to be considering the acquisition of a local baby-care product vendor Shanghai Elsker in China, a move that could strengthen its foothold in the rapidly-growing Chinese baby-care market.
Trials for Alzheimer's Drug Halted After Poor Results
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.
Alzheimer's disease drug shelved after trial failure  BBC News
Medical hope for Alzheimer's drug dashed after treatment fails to ...  Daily Mail (blog)
Related articles »  
Johnson & Johnson Still Hates Women With Heavier Than Normal Periods
Last year the internet was in an uproar because Johnson & Johnson discontinued OB Ultra Absorbency tampons. By internet, I mean women's sites, of course.
Johnson & Johnson unit recalls bone putty
The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.
Synthes recalls bone putty; can catch fire  Bizjournals.com
Related articles »  
Johnson & Johnson loses bid to throw out $258 million Risperdal jury award
Johnson & Johnson lost a bid to have a Louisiana appeals court throw out an award of almost $258 million that a jury ordered it to pay state officials over the marketing of its Risperdal antipsychotic drug.
Here Are The Allegations That Spurred J&J To Pay A $181 Million ...  Business Insider
Johnson Johnson subsidiary to pay record amount to settle off-label ...  Seattle Post Intelligencer (blog)
Related articles »  
Johnson & Johnson makes $50 million milestone payment to California-based ...
Janssen Biotech, part of Johnson & Johnson, will pay a $50 million milestone payment to Pharmacyclics, its collaborator on a new treatment for mantle cell lymphoma.
Related articles »  
Johnson & Johnson releases some Doxil for trials
Manufacturing problems at a Boehringer Ingelheim plant did a double whammy on Johnson & Johnson's ($JNJ) cancer drug, Doxil.
Related articles »